Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

John Bartlett

doi:10.1097/01.idc.0000129851.34508.48

Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

Johns Hopkins Health System

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Number of pages	1
Journal	Infectious Diseases in Clinical Practice
Volume	12
Issue number	3
DOIs	https://doi.org/10.1097/01.idc.0000129851.34508.48
State	Published - Jan 1 2004

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1097/01.idc.0000129851.34508.48

Cite this

@article{1e19b19f7e4941a5ad094941fcdf1d97,

title = "Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors",

author = "John Bartlett",

year = "2004",

month = jan,

day = "1",

doi = "10.1097/01.idc.0000129851.34508.48",

language = "English (US)",

volume = "12",

journal = "Infectious Diseases in Clinical Practice",

issn = "1056-9103",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

AU - Bartlett, John

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=85026144372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026144372&partnerID=8YFLogxK

U2 - 10.1097/01.idc.0000129851.34508.48

DO - 10.1097/01.idc.0000129851.34508.48

M3 - Article

AN - SCOPUS:85026144372

SN - 1056-9103

VL - 12

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

IS - 3

ER -

Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this